✦ LIBER ✦

Phase I trial of r viscumin (INN: aviscumine) given subcutaneously in patients with advanced cancer: A study of the European Organisation for Research and Treatment of Cancer (EORTC protocol number 13001)

✍ Scribed by Lothar Bergmann; Steiner Aamdal; Sandrine Marreaud; Denis Lacombe; Manfred Herold; Takuhiro Yamaguchi; Karin Wilhelm-Ogunbiyi; Hans Lentzen; Heinz Zwierzina

Book ID: 116429669
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 160 KB
Volume: 44
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2008.05.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fotemustine in patients with advanced ga

Fotemustine in patients with advanced gastric cancer, a phase II trial from the EORTC-GITCCG (European organization for research and treatment of cancer, gastrointestinal tract cancer cooperative group)

✍ Ph. Rougier; C. Van Pottelsberghe; T. Kok; B. Paillot; T. Wagener; J. De Greve; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Phase II Study of ET-743 in Advanced Sof

Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial

✍ Le Cesne, A. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 196 KB

1260 Multicenter parallel phase II trial

1260 Multicenter parallel phase II trials of the polo-like kinase 1 inhibitor BI-2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organisation for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)

✍ P. Schöffski; J.Y. Blay; J. DeGreve; E. Brain; J.P. Machiels; J.C. Soria; S. Sle 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Randomised trial of drains versus no dra

Randomised trial of drains versus no drains following radical hysterectomy and pelvic lymph node dissection: a European Organisation for Research and Treatment of Cancer-Gynaecological Cancer Group (EORTC-GCG) study in 234 patients

✍ M. Franchi; J.B. Trimbos; F. Zanaboni; J. v.d. Velden; N. Reed; C. Coens; I. Teo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Predicting toxicities for patients with

Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC–ISG–AGITG)

✍ Martine Van Glabbeke; Jaap Verweij; Paolo G. Casali; John Simes; Axel Le Cesne; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Phase II study of pirarubicin (THP) in p

Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: Study of the clinical screening group of the European Organization for Research and Treatment of Cancer (EORTC)

✍ Chauvergne, J.; Fumoleau, P.; Cappelaere, P.; Metz, R.; Armand, J.P.; Chevallier 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 683 KB